ClinicalTrials.Veeva

Menu
A

Allergy and Asthma Clinical Research | Walnut Creek, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ligelizumab
azelastine hydrochloride
fluticasone propionate
Lanadelumab
azelastineHcl
azelastine Hcl
Indacaterol
Omalizumab
NOC-110
Remibrutinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 25 total trials

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations.

Enrolling
Asthma
Drug: Placebo
Drug: Rocatinlimab

The main aim of this study is to compare the pharmacokinetics (PK) of subcutaneous (SC) administration of TAK-881 with HYQVIA in participants with ch...

Active, not recruiting
Primary Immunodeficiency Diseases (PID)
Biological: TAK-881
Biological: HYQVIA

This is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalatio...

Enrolling
Refractory or Unexplained Chronic Cough
Drug: NOC-110
Other: Placebo

Trial sponsors

Shire logo
Meda Pharmaceuticals logo
Novartis logo
Takeda logo
A
A
Amgen logo
CSL Behring logo
Genentech logo
N

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems